Home LiteratureArticle Details
PMID: 401512 Published · ppublish English Journal Article

Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 118 ·No. 1 ·1977-01-00 ·Pages 256-63

Iwasaki T, Nozima T

Abstract

To investigate the defensive roles and production of interferon and antibodies, C3H/He mice were subjected to various immunosuppressive treatments and infected with influenza virus. In infected normal control mice the pattern of pulmonary viral growth can be divided into three phases. The first phase is characterized by an exponential increase of virus titer, the second by a rapid decrease, and the third by a moderate decrease. At the time of transition from the first phase to the second in pulmonary virus growth, interferon could be detected in the tracheobronchial washings of infected mice, but neutralizing antibodies could not. In infected B cell-deprived mice and infected anti-mu-treated mice, the transition from the first phase to the second occurred without any detectable antibody production, and interferon could be induced in the early stage of infection. However, the pulmonary virus in these mice increased again exponentially until the death of the mice. In infected T cell-deprived mice which could not induce interferon, but produced IgM-neutralizing antibodies, the second phase was not observed after the first phase, but a transient plateau phase could be demonstrated, and then the pulmonary virus increased again exponentially until the death of the mice. In anti-gamma-treated infected mice, pulmonary virus growth and production of interferon and neutralizing antibody were almost similar to those of infected normal control mice except for the absence of IgG neutralizing antibody production. Although anti-alpha-treated infected mice produced interferon and no IgA antibody, the transition from the first exponential increase of pulmonary virus to the second rapid decrease was seen, but then the virus increased exponentially again until the death of the mice. These results suggest that interferon plays an important role in the transition from the first phase to the second, and that T cells are required for interferon induction in mice infected with influenza virus. These data also suggest that IgA antibodies play an important role in the inhibition of virus propagation in the lungs after the disappearance of interferon. Moreover, infected T cell-deprived mice could produce only IgM neutralizing antibodies, but not IgG and IgA antibodies. Therefore, T cells are required for the production of IgG and IgA antibodies and even

MeSH Terms
Animals Antibodies, Anti-Idiotypic Antibodies, Viral/biosynthesis B-Lymphocytes/immunology Immunoglobulin A, Secretory/biosynthesis Immunoglobulin G/biosynthesis Immunoglobulin M/biosynthesis Immunoglobulin alpha-Chains Immunoglobulin gamma-Chains Immunoglobulin mu-Chains Immunologic Deficiency Syndromes/enzymology Influenza A virus Interferons/biosynthesis,physiology Lung/immunology,pathology Male Mice Orthomyxoviridae Infections/immunology,pathology T-Lymphocytes/immunology Time Factors Virus Replication
Chemicals
Antibodies, Anti-Idiotypic Antibodies, Viral Immunoglobulin A, Secretory Immunoglobulin G Immunoglobulin M Immunoglobulin alpha-Chains Immunoglobulin gamma-Chains Immunoglobulin mu-Chains Interferons
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Iwasaki T
Nozima T
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1977-01-00
Pages
256-63
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com